| Year |
Citation |
Score |
| 2020 |
Wu Y, Cook RJ. Assessing the accuracy of predictive models with interval-censored data. Biostatistics (Oxford, England). PMID 32170939 DOI: 10.1093/Biostatistics/Kxaa011 |
0.304 |
|
| 2020 |
Jiang S, Cook RJ, Zeng L. Mitigating bias from intermittent measurement of time-dependent covariates in failure time analysis. Statistics in Medicine. PMID 32126155 DOI: 10.1002/Sim.8517 |
0.322 |
|
| 2019 |
Cook RJ, Lawless JF. Independence conditions and the analysis of life history studies with intermittent observation. Biostatistics (Oxford, England). PMID 31711113 DOI: 10.1093/Biostatistics/Kxz047 |
0.313 |
|
| 2019 |
Lee J, Cook RJ. On estimands arising from misspecified semiparametric rate-based analysis of recurrent episodic conditions. Statistics in Medicine. PMID 31429487 DOI: 10.1002/Sim.8345 |
0.312 |
|
| 2019 |
Harbi SA, Lee K, Chandran V, Cook R, Gladman DD. Sat0360 Remission In Psoriatic Arthritis: Definition And Predictors Annals of the Rheumatic Diseases. 78: 1260-1261. DOI: 10.1136/Annrheumdis-2019-Eular.7248 |
0.325 |
|
| 2018 |
Sun T, Liu Y, Cook RJ, Chen W, Ding Y. Copula-based score test for bivariate time-to-event data, with application to a genetic study of AMD progression. Lifetime Data Analysis. PMID 30560439 DOI: 10.1007/S10985-018-09459-5 |
0.319 |
|
| 2018 |
Zhong Y, Cook RJ. The effect of omitted covariates in marginal and partially conditional recurrent event analyses. Lifetime Data Analysis. PMID 29767377 DOI: 10.1007/S10985-018-9430-Y |
0.313 |
|
| 2018 |
Moon NC, Zeng L, Cook RJ. Tracing studies in cohorts with attrition: Selection models for efficient sampling. Statistics in Medicine. PMID 29682774 DOI: 10.1002/Sim.7646 |
0.302 |
|
| 2018 |
Zeng L, Cook RJ, Lee KA. Design of cancer trials based on progression-free survival with intermittent assessment. Statistics in Medicine. PMID 29582452 DOI: 10.1002/Sim.7641 |
0.307 |
|
| 2017 |
Wu Y, Cook RJ. Variable selection and prediction in biased samples with censored outcomes. Lifetime Data Analysis. PMID 28215038 DOI: 10.1007/S10985-017-9392-5 |
0.333 |
|
| 2016 |
Eder L, Chandran V, Cook R, Gladman D. THU0424 Treatment with Tnf Alpha Blockers Is Associated with Reduced Progression of Atherosclerotic Plaques in Patients with Psoriatic Disease – A Prospective Study Annals of the Rheumatic Diseases. 75: 343.1-343. DOI: 10.1136/Annrheumdis-2016-Eular.1843 |
0.318 |
|
| 2015 |
Boruvka A, Cook RJ. Sieve estimation in a Markov illness-death process under dual censoring. Biostatistics (Oxford, England). PMID 26598559 DOI: 10.1093/Biostatistics/Kxv042 |
0.305 |
|
| 2015 |
Shen H, Cook RJ. Analysis of interval-censored recurrent event processes subject to resolution. Biometrical Journal. Biometrische Zeitschrift. 57: 725-42. PMID 26148993 DOI: 10.1002/Bimj.201400162 |
0.312 |
|
| 2015 |
Aalen OO, Cook RJ, Røysland K. Does Cox analysis of a randomized survival study yield a causal treatment effect? Lifetime Data Analysis. 21: 579-93. PMID 26100005 DOI: 10.1007/S10985-015-9335-Y |
0.332 |
|
| 2015 |
Zeng L, Cook RJ, Wen L, Boruvka A. Bias in progression-free survival analysis due to intermittent assessment of progression. Statistics in Medicine. 34: 3181-93. PMID 26011411 DOI: 10.1002/Sim.6529 |
0.312 |
|
| 2015 |
Wu Y, Cook RJ. Penalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis. Biometrics. PMID 25773729 DOI: 10.1111/Biom.12302 |
0.316 |
|
| 2015 |
Sholapur NS, Hillis CM, Crowther MA, Leber B, Khokhar F, Cook R, Barr R, Heddle NM. Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review Blood. 126: 5252-5252. DOI: 10.1182/Blood.V126.23.5252.5252 |
0.317 |
|
| 2015 |
Boruvka A, Cook RJ. A Cox-Aalen Model for Interval-censored Data Scandinavian Journal of Statistics. 42: 414-426. DOI: 10.1111/Sjos.12113 |
0.307 |
|
| 2014 |
Shen H, Cook RJ. A dynamic Mover-Stayer model for recurrent event processes subject to resolution. Lifetime Data Analysis. 20: 404-23. PMID 23784557 DOI: 10.1007/S10985-013-9271-7 |
0.301 |
|
| 2014 |
Wu L, Cook RJ. Marginal Methods for Multivariate Failure Times Under Event-Dependent Censoring International Journal of Statistics and Probability. 3. DOI: 10.5539/Ijsp.V3N3P111 |
0.322 |
|
| 2013 |
Coleman RE, Lipton A, Costa L, Cook RJ, Lee KA, Saad F, Brown JE, Terpos E, Major PP, Kohno N, Smith M, Body JJ. Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trials. Journal of Bone Oncology. 2: 70-6. PMID 26909273 DOI: 10.1016/J.Jbo.2013.01.002 |
0.309 |
|
| 2013 |
Diao L, Cook RJ, Lee KA. A copula model for marked point processes. Lifetime Data Analysis. 19: 463-89. PMID 23660874 DOI: 10.1007/S10985-013-9259-3 |
0.313 |
|
| 2013 |
Cook RJ, Lee KA, Cuerden M, Cotton CA. Inverse probability weighted estimating equations for randomized trials in transfusion medicine. Statistics in Medicine. 32: 4380-99. PMID 23625873 DOI: 10.1002/Sim.5827 |
0.322 |
|
| 2013 |
Shen H, Cook RJ. Regression with incomplete covariates and left-truncated time-to-event data. Statistics in Medicine. 32: 1004-15. PMID 22927306 DOI: 10.1002/Sim.5581 |
0.332 |
|
| 2013 |
Al-Shamsi HO, Anjum M, Al Farsi A, Shen H, Linkins L, Cook RJ, Major P. Thrombotic events in patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab. Journal of Clinical Oncology. 31: 540-540. DOI: 10.1200/Jco.2013.31.4_Suppl.540 |
0.315 |
|
| 2013 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. SAT0288 Male Gender is Associated with Accelerated Radiographic Progression in Axial Damage but not with Progression of Peripheral Damage Annals of the Rheumatic Diseases. 72: A681.1-A681. DOI: 10.1136/Annrheumdis-2013-Eular.2013 |
0.306 |
|
| 2013 |
Haddad A, Thavaneswaran A, Arruza IR, Chandran V, Cook R, Gladman D. SAT0273 The Characteristics and Predictors of Minimal Disease Activity in Patients with Psoriatic Arthritis on TNF Blockers Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1998 |
0.315 |
|
| 2013 |
Wu L, Cook RJ. The Design of Intervention Trials Involving Recurrent and Terminal Events Statistics in Biosciences. 5: 261-285. DOI: 10.1007/S12561-013-9083-Z |
0.314 |
|
| 2012 |
Wu L, Cook RJ. Misspecification of Cox regression models with composite endpoints. Statistics in Medicine. 31: 3545-62. PMID 22736519 DOI: 10.1002/Sim.5436 |
0.325 |
|
| 2011 |
Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, Gladman DD. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care & Research. 63: 619-22. PMID 21452273 DOI: 10.1002/Acr.20401 |
0.304 |
|
| 2011 |
Coleman R, Cook R, Hirsh V, Major P, Lipton A. Zoledronic acid use in cancer patients: more than just supportive care? Cancer. 117: 11-23. PMID 21235033 DOI: 10.1002/Cncr.25529 |
0.305 |
|
| 2011 |
Major PP, Cook RJ, Chen BL, Zheng M. Survival-adjusted multiple-event analysis for the evaluation of treatment effects of zoledronic Acid in patients with bone metastases from solid tumors. Supportive Cancer Therapy. 2: 234-40. PMID 18628179 DOI: 10.3816/Sct.2005.N.017 |
0.32 |
|
| 2010 |
Cook RJ, Andersen PK. Recurrent event analyses. Lifetime Data Analysis. 16: 449-50. PMID 20730624 DOI: 10.1007/S10985-010-9184-7 |
0.32 |
|
| 2010 |
Brown JE, Cook RJ, Lipton A, Costa L, Coleman RE. Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast Cancer Research and Treatment. 123: 767-79. PMID 20574672 DOI: 10.1007/S10549-010-0981-1 |
0.312 |
|
| 2010 |
Pullenayegum EM, Cook RJ. The analysis of treatment effects for recurring episodic conditions. Statistics in Medicine. 29: 1539-58. PMID 20535764 DOI: 10.1002/Sim.3882 |
0.334 |
|
| 2010 |
Chen B, Yi GY, Cook RJ. Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process. Statistics in Medicine. 29: 1175-89. PMID 20437455 DOI: 10.1002/Sim.3804 |
0.312 |
|
| 2010 |
Terpos E, Berenson J, Cook RJ, Lipton A, Coleman RE. Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease. Leukemia. 24: 1043-9. PMID 20376081 DOI: 10.1038/Leu.2010.62 |
0.327 |
|
| 2010 |
Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. The Journal of Rheumatology. 37: 809-15. PMID 20231209 DOI: 10.3899/Jrheum.091059 |
0.31 |
|
| 2010 |
Cook RJ, Lawless JF, Lee KA. A copula-based mixed Poisson model for bivariate recurrent events under event-dependent censoring. Statistics in Medicine. 29: 694-707. PMID 20146240 DOI: 10.1002/Sim.3830 |
0.332 |
|
| 2010 |
Smith MR, Cook RJ, Nelson JB. Natural history of castration-resistant nonmetastatic prostate cancer: Secondary analyses of a multicenter randomized controlled trial. Journal of Clinical Oncology. 28: 4653-4653. DOI: 10.1200/Jco.2010.28.15_Suppl.4653 |
0.302 |
|
| 2010 |
Cook RJ, Yi GY, Lee K. Sequential Testing with Recurrent Events over Multiple Treatment Periods Statistics in Biosciences. 2: 137-153. DOI: 10.1007/S12561-010-9030-1 |
0.341 |
|
| 2009 |
Zeng L, Cook RJ, Warkentin TE. Regression analysis with a misclassified covariate from a current status observation scheme. Biometrics. 66: 415-25. PMID 19645696 DOI: 10.1111/J.1541-0420.2009.01299.X |
0.321 |
|
| 2009 |
Cook RJ, Bergeron PJ, Boher JM, Liu Y. Two-stage design of clinical trials involving recurrent events. Statistics in Medicine. 28: 2617-38. PMID 19579215 DOI: 10.1002/Sim.3645 |
0.33 |
|
| 2009 |
Chen BE, Cook RJ. The analysis of multivariate recurrent events with partially missing event types. Lifetime Data Analysis. 15: 41-58. PMID 18622700 DOI: 10.1007/S10985-008-9091-3 |
0.573 |
|
| 2009 |
Cook RJ, Lawless JF, Lakhal-Chaieb L, Lee KA. Robust estimation of mean functions and treatment effects for recurrent events under event-dependent censoring and termination: application to skeletal complications in cancer metastatic to bone Journal of the American Statistical Association. 104: 60-75. DOI: 10.1198/Jasa.2009.0004 |
0.338 |
|
| 2009 |
Sutradhar R, Cook RJ. A Bivariate Mover–Stayer Model for Interval-Censored Recurrent Event Data: Application to Joint Damage in Rheumatology Communications in Statistics - Theory and Methods. 38: 3389-3405. DOI: 10.1080/03610920802663315 |
0.309 |
|
| 2008 |
Lipton A, Cook R, Saad F, Major P, Garnero P, Terpos E, Brown JE, Coleman RE. Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer. 113: 193-201. PMID 18459173 DOI: 10.1002/Cncr.23529 |
0.302 |
|
| 2008 |
Hirsh V, Major PP, Lipton A, Cook RJ, Langer CJ, Smith MR, Brown JE, Coleman RE. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 228-36. PMID 18317064 DOI: 10.1097/Jto.0B013E3181651C0E |
0.319 |
|
| 2008 |
Cook RJ, Zeng L, Lee KA. A multistate model for bivariate interval-censored failure time data. Biometrics. 64: 1100-9. PMID 18218064 DOI: 10.1111/J.1541-0420.2007.00978.X |
0.316 |
|
| 2008 |
Cook RJ, White BJ, Yi GY, Lee KA, Warkentin TE. Analysis of a nonsusceptible fraction with current status data. Statistics in Medicine. 27: 2715-30. PMID 17943708 DOI: 10.1002/Sim.3102 |
0.309 |
|
| 2008 |
He X, Tong X, Sun J, Cook RJ. Regression analysis of multivariate panel count data. Biostatistics (Oxford, England). 9: 234-48. PMID 17626224 DOI: 10.1093/Biostatistics/Kxm025 |
0.332 |
|
| 2008 |
Cook RJ, Lee KA, Li H. Non-inferiority trial design for recurrent events. Statistics in Medicine. 26: 4563-77. PMID 17380542 DOI: 10.1002/Sim.2885 |
0.332 |
|
| 2008 |
Cook RJ, Hirsh V, Major PP, Saad F, Dias R, Lipton A, Coleman RE. Meta-analysis of effects of zoledronic acid (ZOL) on survival in metastatic bone disease (MBD): Survival in patients with high bone turnover Journal of Clinical Oncology. 26: 20562-20562. DOI: 10.1200/Jco.2008.26.15_Suppl.20562 |
0.302 |
|
| 2008 |
Sutradhar R, Cook RJ. Analysis of interval-censored data from clustered multistate processes: application to joint damage in psoriatic arthritis Journal of the Royal Statistical Society: Series C (Applied Statistics). 57: 553-566. DOI: 10.1111/J.1467-9876.2008.00630.X |
0.303 |
|
| 2007 |
Smith MR, Cook RJ, Coleman R, Brown J, Lipton A, Major P, Hei YJ, Saad F. Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer Urology. 70: 315-319. PMID 17826496 DOI: 10.1016/J.Urology.2007.03.071 |
0.313 |
|
| 2007 |
Arnold DM, Donahoe L, Tkaczyk AJ, Heels-Ansdell D, Zytaruk N, Cook R, Webert KE, McDonald E, Cook DJ. Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clinical and Investigative Medicine. 30: 93-102. PMID 17716547 DOI: 10.25011/Cim.V30I2.985 |
0.328 |
|
| 2007 |
Lee JC, Gladman DD, Schentag CT, Cook RJ. The long-term use of azathioprine in patients with psoriatic arthritis. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 7: 160-5. PMID 17039121 DOI: 10.1097/00124743-200106000-00005 |
0.303 |
|
| 2007 |
Berenson J, Cook R, Lipton A, Coleman R, Terpos E. Increased Levels of Urinary N-Telopeptide of Type I Collagen Correlate with Reduced Survival in Patients with Advanced Multiple Myeloma. Blood. 110: 1499-1499. DOI: 10.1182/Blood.V110.11.1499.1499 |
0.311 |
|
| 2007 |
Terpos E, Cook R, Coleman R, Lipton A, Berenson J. Predictors for Skeletal-Related Events in Patients with Advanced Multiple Myeloma. Blood. 110: 1482-1482. DOI: 10.1182/Blood.V110.11.1482.1482 |
0.334 |
|
| 2006 |
Cook RJ, Major P. Multistate analysis of skeletal events in patients with bone metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6264s-6269s. PMID 17062711 DOI: 10.1158/1078-0432.Ccr-06-0654 |
0.352 |
|
| 2006 |
Walter SD, Guyatt G, Montori VM, Cook R, Prasad K. A new preference-based analysis for randomized trials can estimate treatment acceptability and effect in compliant patients. Journal of Clinical Epidemiology. 59: 685-696. PMID 16765271 DOI: 10.1016/J.Jclinepi.2005.11.016 |
0.301 |
|
| 2006 |
Boher J, Cook RJ. Implications of model misspecification in robust tests for recurrent events. Lifetime Data Analysis. 12: 69-95. PMID 16583300 DOI: 10.1007/S10985-005-7221-8 |
0.326 |
|
| 2006 |
Berruti A, Dogliotti L, Tampellini M, Lipton A, Hirsh V, Saad F, Liati P, Shirina N, Cook R, Hei YL. Effect of zoledronic acid (Z) treatment based on serum parathyroid hormone (PTH) levels in patients (pts) with malignant bone disease Journal of Clinical Oncology. 24: 8610-8610. DOI: 10.1200/Jco.2006.24.18_Suppl.8610 |
0.301 |
|
| 2006 |
Saad F, Coleman RE, Cook R, Smith MR, Brown JE, Hei JY, Chen YM. Predictors of clinical outcome in patients with bone metastases from prostate cancer Journal of Clinical Oncology. 24: 4555-4555. DOI: 10.1200/Jco.2006.24.18_Suppl.4555 |
0.301 |
|
| 2005 |
Cook RJ, Wei W, Yi GY. Robust tests for treatment effects based on censored recurrent event data observed over multiple periods. Biometrics. 61: 692-701. PMID 16135020 DOI: 10.1111/J.1541-0420.2005.00357.X |
0.4 |
|
| 2005 |
Coleman RE, Major P, Lipton A, Brown JE, Lee KA, Smith M, Saad F, Zheng M, Hei YJ, Seaman J, Cook R. Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4925-35. PMID 15983391 DOI: 10.1200/Jco.2005.06.091 |
0.315 |
|
| 2005 |
Heddle NM, Cook RJ, Blajchman MA, Barty RL, Sigouin CS, Boye DM, Nelson EJ, Kelton JG. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial. Transfusion. 45: 896-903. PMID 15934987 DOI: 10.1111/J.1537-2995.2005.04233.X |
0.313 |
|
| 2005 |
Chen BE, Cook RJ, Lawless JF, Zhan M. Statistical methods for multivariate interval-censored recurrent events. Statistics in Medicine. 24: 671-91. PMID 15558580 DOI: 10.1002/Sim.1936 |
0.584 |
|
| 2005 |
Cook RJ, Zeng L, Yi GY. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation. Biometrics. 60: 820-8. PMID 15339307 DOI: 10.1111/J.0006-341X.2004.00234.X |
0.316 |
|
| 2005 |
Lipton A, Hei Y, Coleman R, Major P, Cook R. Suppression of bone turnover markers by zoledronic acid and correlation with clinical outcome Journal of Clinical Oncology. 23: 532-532. DOI: 10.1200/Jco.2005.23.16_Suppl.532 |
0.31 |
|
| 2004 |
Chen BE, Cook RJ. Tests for multivariate recurrent events in the presence of a terminal event. Biostatistics (Oxford, England). 5: 129-43. PMID 14744832 DOI: 10.1093/Biostatistics/5.1.129 |
0.588 |
|
| 2004 |
Chen EB, Cook RJ. Regression modeling with recurrent events and time-dependent interval-censored marker data. Lifetime Data Analysis. 9: 275-91. PMID 14649846 DOI: 10.1023/A:1025888820636 |
0.324 |
|
| 2004 |
Steiner SH, Cook RJ, Farewell VT, Treasure T. Monitoring surgical performance using risk-adjusted cumulative sum charts. Biostatistics (Oxford, England). 1: 441-52. PMID 12933566 DOI: 10.1093/Biostatistics/1.4.441 |
0.629 |
|
| 2004 |
Major PP, Cook RJ. Clinical Endpoints for Assessing Bisphosphonate Efficacy in the Prevention of Skeletal Complications of Bone Metastases European Urology Supplements. 3: 34-39. DOI: 10.1016/J.Eursup.2004.08.010 |
0.348 |
|
| 2003 |
Cook RJ, Wei W. Conditional analysis of mixed Poisson processes with baseline counts: implications for trial design and analysis. Biostatistics (Oxford, England). 4: 479-94. PMID 12925513 DOI: 10.1093/Biostatistics/4.3.479 |
0.37 |
|
| 2003 |
Cook DA, Steiner SH, Cook RJ, Farewell VT, Morton AP. Monitoring the evolutionary process of quality: risk-adjusted charting to track outcomes in intensive care. Critical Care Medicine. 31: 1676-82. PMID 12794403 DOI: 10.1097/01.Ccm.0000065273.63224.A8 |
0.604 |
|
| 2003 |
Cook RJ, Chen BE, Major P. Marginal Analysis of Point Processes with Competing Risks Handbook of Statistics. 23: 349-361. DOI: 10.1016/S0169-7161(03)23019-4 |
0.555 |
|
| 2002 |
Cook RJ, Lawless JF. Analysis of repeated events Statistical Methods in Medical Research. 11: 141-166. PMID 12040694 DOI: 10.1191/0962280202Sm278Ra |
0.311 |
|
| 2002 |
Cook RJ, Wei W. Selection effects in randomized trials with count data. Statistics in Medicine. 21: 515-31. PMID 11836733 DOI: 10.1002/Sim.1014 |
0.373 |
|
| 2001 |
Steiner SH, Cook RJ, Farewell VT. Risk-adjusted monitoring of binary surgical outcomes. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 21: 163-9. PMID 11386623 DOI: 10.1177/0272989X0102100301 |
0.633 |
|
| 2000 |
Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. Journal of Clinical Epidemiology. 53: 459-68. PMID 10812317 DOI: 10.1016/S0895-4356(99)00206-1 |
0.617 |
|
| 1999 |
Steiner SH, Cook RJ, Farewell VT. Monitoring paired binary surgical outcomes using cumulative sum charts. Statistics in Medicine. 18: 69-86. PMID 9990693 DOI: 10.1002/(Sici)1097-0258(19990115)18:1<69::Aid-Sim966>3.0.Co;2-L |
0.623 |
|
| 1999 |
Ng ETM, Cook RJ. Adjusted Score Tests of Homogeneity for Poisson Processes Journal of the American Statistical Association. 94: 308-319. DOI: 10.1080/01621459.1999.10473846 |
0.301 |
|
| 1997 |
Cook RJ, Lawless JF. Marginal analysis of recurrent events and a terminating event Statistics in Medicine. 16: 911-924. PMID 9160488 DOI: 10.1002/(Sici)1097-0258(19970430)16:8<911::Aid-Sim544>3.0.Co;2-I |
0.306 |
|
| 1997 |
Cook RJ, Walter SD. A Logistic Model for Trend in 2 x 2 x K Tables with Applications to Meta- Analyses Biometrics. 53: 352. DOI: 10.2307/2533120 |
0.303 |
|
| 1996 |
Cook RJ, Lawless JF. Interim monitoring of longitudinal comparative studies with recurrent event responses Biometrics. 52: 1311-1323. PMID 8962455 DOI: 10.2307/2532846 |
0.306 |
|
| 1996 |
Cook RJ, Lawless JF, Nadeau C. Robust tests for treatment comparisons based on recurrent event responses Biometrics. 52: 557-571. PMID 8672703 DOI: 10.2307/2532895 |
0.31 |
|
| 1996 |
Cook RJ. The design and analysis of randomized trials with recurrent events. Statistics in Medicine. 14: 2081-98. PMID 8552888 DOI: 10.1002/Sim.4780141903 |
0.315 |
|
| 1996 |
Cook RJ, Farewell VT. Multiplicity Considerations in the Design and Analysis of Clinical Trials Journal of the Royal Statistical Society. Series a (Statistics in Society). 159: 93. DOI: 10.2307/2983471 |
0.633 |
|
| 1996 |
Cook RJ, Willan AR. Design Considerations in Crossover Trials with a Single Interim Analysis and Serial Patient Entry Biometrics. 52: 732. DOI: 10.2307/2532913 |
0.318 |
|
| 1996 |
Cook RJ, Farewell VT. Incorporating Surrogate Endpoints into Group Sequential Trials Biometrical Journal. 38: 119-130. DOI: 10.1002/Bimj.4710380112 |
0.65 |
|
| 1995 |
Cook RJ, Farewell VT. Conditional inference for subject-specific and marginal agreement: Two families of agreement measures Canadian Journal of Statistics. 23: 333-344. DOI: 10.2307/3315378 |
0.616 |
|
| 1995 |
Cook RJ. Interim Analyses in 2 x 2 Crossover Trials Biometrics. 51: 932. DOI: 10.2307/2532994 |
0.301 |
|
| 1994 |
Cook RJ, Farewell VT. Guidelines for Monitoring Efficacy and Toxicity Responses in Clinical Trials Biometrics. 50: 1146. DOI: 10.2307/2533451 |
0.634 |
|
| 1992 |
Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN. The natural history of asymptomatic urolithiasis. The Journal of Urology. 147: 319-321. PMID 1732583 DOI: 10.1016/S0022-5347(17)37225-7 |
0.309 |
|
| 1992 |
Farewell VT, Cook RJ. [Evaluating Therapeutic Interventions: Some Issues and Experiences]: Comment Statistical Science. 7. DOI: 10.1214/Ss/1177011132 |
0.587 |
|
| Show low-probability matches. |